substantially reduce waiting times and waiting list mortality for children in need of a liver transplant.


1. Whitington PF, Balistreri WF. Liver transplantation in pediatrics: indications, contraindications, and pretransplant management. J Pediatr 1991; 118:169-77.

2. Malago M, Rogiers X, Broelsch CE. Reduced-size hepatic allografts. Ann Rev Med 1995; 46:507-12.

3. Sandler AD, Azarow KS, Superina RA. The impact of a previous Kasai procedure on liver transplantation for biliary atresia. J Pediatr Surg 1997; 32:416-9.

4. Shaw BW, Jr., Iwatsuki S, Bron K, Starzl TE. Portal vein grafts in hepatic transplantation. Surg, Gynecol Obstet 1985; 161:66-8.

5. Nery J, Jacque J, Weppler D et al. Routine use of the piggyback technique in pedi-atric orthotopic liver transplantation. J Pediatr Surg 1996; 31:1644-7.

6. Bilik R, Greig P, Langer B, Superina RA. Survival after reduced-size liver transplantation is dependent on pretransplant status. J Pediatr Surg 1993; 28:1307-11.

7. Otte JB, de Ville de Goyet J, Reding R et al. Pediatric liver transplantation: From the full-size liver graft to reduced, split, and living related liver transplantation. Pediatr Surg Intern 1998; 13:308-18.

8. Pichlmayr R, Ringe B, Gubernatis G, Hauss J, Bunzendahl H. [Transplantation of a donor liver to 2 recipients (splitting transplantation)—A new method in the further development of segmental liver transplantation]. Langenbecks Archiv fur Chirurgie 1988; 373:127-30.

9. Rogiers X, Malago M, Habib N et al. In situ splitting of the liver in the heart-beating cadaveric organ donor for transplantation in two recipients [see comments]. Transplantation 1995; 59:1081-3.

10. Mori K, Nagata I, Yamagata S et al. The introduction of microvascular surgery to hepatic artery reconstruction in living-donor liver transplantation—Its surgical advantages compared with conventional procedures. Transplantation 1992; 54:263-8.

11. Leaker MT, Brooker LA, Mitchell LG, Weitz JI, Superina R, Andrew ME. Fibrin clot lysis by tissue plasminogen activator (tPA) is impaired in plasma from pediatric patients undergoing orthotopic liver transplantation. Transplantation 1995; 60:144-7.

12. Bilik R, Yellen M, Superina RA. Surgical complications in children after liver transplantation. J Pediatr Surg 1992; 27:1371-5.

13. Langnas AN, Marujo W, Stratta RJ, Wood RP, Li SJ, Shaw BW. Hepatic allograft rescue following arterial thrombosis. Role of urgent revascularization. Transplantation 1991; 51:86-90.

14. King SM, Superina R, Andrews W et al. Randomized comparison of ganciclovir plus intravenous immune globulin (IVIG) with IVIG alone for prevention of primary cytomegalovirus disease in children receiving liver transplants. Clin Infec Dis 1997; 25:1173-9.

15. Whitington PF, Alonso EM, Millis JM. Potential role of Neoral in pediatric liver transplantation. Transpl Proc 1996; 28:2267-9.

16. Superina RA, Strong DK, Acal LA, DeLuca E. Relative bioavailability of Sandimmune and Sandimmune Neoral in pediatric liver recipients. Transpl Proc 1994; 26:2979-80.

17. Morgan G, Superina RA. Lymphoproliferative disease after pediatric liver transplantation. J Pediatr Surg 1994; 29:1192-6.

0 0

Post a comment